595 related articles for article (PubMed ID: 20807067)
1. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.
Seo WS; Sung HM; Sea HS; Bai DS
J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):197-205. PubMed ID: 18439116
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.
Yoo HK; Joung YS; Lee JS; Song DH; Lee YS; Kim JW; Kim BN; Cho SC
J Clin Psychiatry; 2013 Aug; 74(8):e772-80. PubMed ID: 24021518
[TBL] [Abstract][Full Text] [Related]
6. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
[TBL] [Abstract][Full Text] [Related]
7. Clinical effectiveness of aripiprazole in short-term treatment of tic disorder in children and adolescents: a naturalistic study.
Ho CS; Chiu NC; Tseng CF; Huang YL
Pediatr Neonatol; 2014 Feb; 55(1):48-52. PubMed ID: 23920131
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.
Budman C; Coffey BJ; Shechter R; Schrock M; Wieland N; Spirgel A; Simon E
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):509-15. PubMed ID: 18928415
[TBL] [Abstract][Full Text] [Related]
9. [A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China].
Liu ZS; Chen YH; Zhong YQ; Zou LP; Wang H; Sun D; Wang DB; Liao JX
Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):572-6. PubMed ID: 22093417
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.
Ercan ES; Uysal T; Ercan E; Akyol Ardic U
Pharmacopsychiatry; 2012 Jan; 45(1):13-9. PubMed ID: 21993869
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study.
Stephens RJ; Bassel C; Sandor P
J Child Adolesc Psychopharmacol; 2004; 14(2):255-66. PubMed ID: 15319022
[TBL] [Abstract][Full Text] [Related]
12. The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.
Wang LJ; Chou WJ; Chou MC; Gau SS
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):442-8. PubMed ID: 27028456
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents.
Sallee F; Kohegyi E; Zhao J; McQuade R; Cox K; Sanchez R; van Beek A; Nyilas M; Carson W; Kurlan R
J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):771-781. PubMed ID: 28686474
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.
Stigler KA; Diener JT; Kohn AE; Li L; Erickson CA; Posey DJ; McDougle CJ
J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):265-74. PubMed ID: 19519261
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Meta-Analysis.
Liu Y; Ni H; Wang C; Li L; Cheng Z; Weng Z
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):436-41. PubMed ID: 26914764
[TBL] [Abstract][Full Text] [Related]
16. [Aripiprazole - a medical treatment alternative for Tourette Syndrome in childhood and adolescence].
Frölich J; Starck M; Banaschewski T; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2010 Jul; 38(4):291-8. PubMed ID: 20617499
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome.
McCracken JT; Suddath R; Chang S; Thakur S; Piacentini J
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):501-8. PubMed ID: 18928414
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
[TBL] [Abstract][Full Text] [Related]
19. Open label aripiprazole in the treatment of youth with tic disorders.
Murphy TK; Mutch PJ; Reid JM; Edge PJ; Storch EA; Bengtson M; Yang M
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):441-7. PubMed ID: 19702496
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
